NEWS & EVENTS 

CYTES BIOTECHNOLOGIES 5TH ANNIVERSARY!

We have some exciting news… Today is our 5th Anniversary!

Read More

3D SPHEROID QUALIFIED AT 2D PRICE!

We are happy to announce that we have 3D Spheroid qualified Hepatocytes available at 2D price until August 31th

Read More

September 2019 - Eurotox 2019

Our team successfully attended Eurotox 2019, organized by the Finnish Society of Toxicology and held in Helsinki (Finland), from the 8th to 11th of September.

Read More




June 2019 - New Partner: Caltag Medsystems

We are happy to announce our new partner in Europe (except Germany): Caltag Medsystems

Read More

May 2019 - CHINA

Cytes Biotechnologies travelled to China as part of the business mission organized by ACCIÓ.

Read More

April 2019 - India

Cytes Biotechnologies travelled to India as part of the business mission

Read More

April 2019 - Drug Discovery Summit

Dr. Natalia Sánchez-Romero, our R&D director, attended the 3rd Annual Clinical Trials and Drug Discovery Summit meeting. 

Read More

April 2019 - EASL: The International Liver Congress

Our R&D Director, Dr. Natalia Sánchez-Romero, attended to EASL - The International Liver Congress held in Vienna (Austria),on April.

Read More

February 2019 - New Partner:    Zen-Bio

We are happy to announce our new partner in the USA & Canada: Zen-Bio


Read More




February 2019 - BioAsia

Cytes Biotechnologies attended the 2019 BioAsia

Read More

January 2019 - R&D Department

We are happy to announce we hired Dr. Natalia Sánchez-Romero to become the Director of our R&D departmen

Read More

October 2018 - BioJapan

After the successful attendance at BioJapan 2017, Cytes Biotechnologies has participate again in the event.

Read More

September 2018 - Eurotox - Brussels

Thanks to our partnership with PRIMACYT we have been the 54th Congress of the European Societies for Toxicology (EUROTOX 2018)

Read More

June 2018 - Bio International Convention 2018

Cytes Biotechnologies attended the 2018 BIO INTERNATIONAL CONVENTION

Read More

October 2017 - BioJapan

Cytes Biotechnologies attended for the first time BioJapan

Read More